IN2013MU02582A - - Google Patents

Info

Publication number
IN2013MU02582A
IN2013MU02582A IN2582MU2013A IN2013MU02582A IN 2013MU02582 A IN2013MU02582 A IN 2013MU02582A IN 2582MU2013 A IN2582MU2013 A IN 2582MU2013A IN 2013MU02582 A IN2013MU02582 A IN 2013MU02582A
Authority
IN
India
Prior art keywords
tapentadol
salt
relates
present
orally disintegrating
Prior art date
Application number
Inventor
Kumar Yatendra
Swain Kapileswar
Suggala Vijay
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN2582MU2013 priority Critical patent/IN2013MU02582A/en
Publication of IN2013MU02582A publication Critical patent/IN2013MU02582A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Abstract The present invention relates to orally disintegrating pharmaceutical compositions comprising Tapentadol or salt thereof. The present invention also relates to a process for the preparation of orally disintegrating pharmaceutical composition of Tapentadol or salt thereof along with taste masking agent and one or more pharmaceutically acceptable excipients to provide rapid onset of action and mask the bitter taste of Tapentadol or salt thereof.
IN2582MU2013 2013-08-05 2013-08-05 IN2013MU02582A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2582MU2013 IN2013MU02582A (en) 2013-08-05 2013-08-05

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2582MU2013 IN2013MU02582A (en) 2013-08-05 2013-08-05

Publications (1)

Publication Number Publication Date
IN2013MU02582A true IN2013MU02582A (en) 2015-06-12

Family

ID=54199326

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2582MU2013 IN2013MU02582A (en) 2013-08-05 2013-08-05

Country Status (1)

Country Link
IN (1) IN2013MU02582A (en)

Similar Documents

Publication Publication Date Title
EA201892395A1 (en) DRUG COMPOSITIONS OF LSD1 INHIBITOR
PH12016501750A1 (en) Human plasma kallikrein inhibitors
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12015502002A1 (en) Tripeptide epoxy ketone protease inhibitors
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
MX368903B (en) THERAPEUTIC COMPOUNDS and USES THEREOF.
IN2013MU03583A (en)
PH12016502352A1 (en) Pharmaceutical composition
JO3326B1 (en) Tripeptide Epoxy Ketone Protease Inhibitors
TW201613578A (en) Pharmaceutical combinations
MX2021010297A (en) Human plasma kallikrein inhibitors.
DOP2013000314A (en) TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
MX2015007488A (en) Topical ophthalmological pharmaceutical composition containing regorafenib.
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
IN2013MU02581A (en)
IN2013MU02582A (en)
IN2013MU03428A (en)
MX2018013428A (en) Tablet-in-tablet pharmaceutical composition comprising cyclophosphamide and capecitabine.
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
UA81932U (en) Rotrin-denta, combined pharmaceutical gel composition for treating inflammations of oral mucosa
IN2013MU03639A (en)